Cargando…

Omitting Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy for Clinically Node Negative HER2 Positive and Triple Negative Breast Cancer: A Pooled Analysis

SIMPLE SUMMARY: Following neoadjuvant systemic therapy (NAST), patients who were clinically node-negative at diagnosis still routinely undergo sentinel lymph node biopsy (SLNB) to detect nodal disease. Surgical staging of the axilla is currently the standard of care, including for those who achieve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alamoodi, Munaser, Wazir, Umar, Mokbel, Kinan, Patani, Neill, Varghese, Jajini, Mokbel, Kefah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340379/ https://www.ncbi.nlm.nih.gov/pubmed/37444434 http://dx.doi.org/10.3390/cancers15133325

Ejemplares similares

Exploring the interface zone in breast cancer: implications for surgical strategies and beyond
por: Mokbel, Kefah, et al.
Publicado: (2023)

Pathologic Response of Associated Ductal Carcinoma In Situ to Neoadjuvant Systemic Therapy: A Systematic Review
por: Wazir, Umar, et al.
Publicado: (2022)

Redefining axillary lymph node dissection in mastectomy: insights from the SINODAR-ONE study
por: Mokbel, Kefah, et al.
Publicado: (2023)

Are online prediction tools a valid alternative to genomic profiling in the context of systemic treatment of ER-positive breast cancer?
por: Wazir, Umar, et al.
Publicado: (2017)

The Evolving Role of Marked Lymph Node Biopsy (MLNB) and Targeted Axillary Dissection (TAD) after Neoadjuvant Chemotherapy (NACT) for Node-Positive Breast Cancer: Systematic Review and Pooled Analysis
por: Swarnkar, Parinita K., et al.
Publicado: (2021)

The competent sentinel node: an association with an axillary presentation and an occult or a small primary invasive breast carcinoma
por: Mansfield, Lucy, et al.
Publicado: (2006)

Ductal Carcinoma In Situ: Recent Advances and Future Prospects
por: Lambert, Kelly, et al.
Publicado: (2012)

Breast Auto-Augmentation: A Versatile Method of Breast Rehabilitation—A Retrospective Series of 107 Procedures
por: Kirwan, Laurence, et al.
Publicado: (2015)

The Clinical Implications of Poly Implant Prothèse Breast Implants: An Overview
por: Wazir, Umar, et al.
Publicado: (2015)

The Evolving Role of Radiofrequency Guided Localisation in Breast Surgery: A Systematic Review
por: Tayeh, Salim, et al.
Publicado: (2021)

Simultaneous Salvage Auto-augmentation: Contemporary Strategy for Management of the Breast Explantation Patient
por: Kirwan, Laurence, et al.
Publicado: (2023)

Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review
por: Wazir, Umar, et al.
Publicado: (2016)

Current management of the axilla in patients with clinically node-negative breast cancer: a nationwide survey of United Kingdom breast surgeons
por: Mansfield, Lucy, et al.
Publicado: (2007)

Brain-derived neurotrophic factor expression predicts adverse pathological & clinical outcomes in human breast cancer
por: Patani, Neill, et al.
Publicado: (2011)

Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer
por: Patani, Neill, et al.
Publicado: (2010)

Axillary Lymph Node Dissection Can Be Omitted in Breast Cancer Patients With Mastectomy and False-Negative Frozen Section in Sentinel Lymph Node Biopsy
por: Si, Jing, et al.
Publicado: (2022)

Breast Lipofilling: A Review of Current Practice
por: Kasem, Abdul, et al.
Publicado: (2015)

Could axillary lymph node dissection be omitted in the mastectomy patient with tumor positive sentinel node?
por: You, Ji Young, et al.
Publicado: (2023)

The mRNA expression of SATB1 and SATB2 in human breast cancer
por: Patani, Neill, et al.
Publicado: (2009)

Omitting Sentinel Lymph Node Biopsy in Elderly Patients: A Lost Opportunity?
por: Tuttle, Todd M., et al.
Publicado: (2021)

False-Negative Sentinel Node Biopsy
por: Nieweg, Omgo E.
Publicado: (2009)

Tumour suppressor function of MDA-7/IL-24 in human breast cancer
por: Patani, Neill, et al.
Publicado: (2010)

Preoperative Nomogram for Predicting Sentinel Lymph Node Metastasis Risk in Breast Cancer: A Potential Application on Omitting Sentinel Lymph Node Biopsy
por: Hu, Xi’E, et al.
Publicado: (2021)

Correction to: Omitting Sentinel Lymph Node Biopsy in Elderly Patients: A Lost Opportunity?
por: Tuttle, Todd M., et al.
Publicado: (2021)

Can late lymphoscintigraphy be omitted in the sentinel node procedure in early‐stage vulvar cancer?
por: Thissen, Daniek, et al.
Publicado: (2022)

Oncological outcome and patient satisfaction with skin-sparing mastectomy and immediate breast reconstruction: a prospective observational study
por: Reefy, Sara, et al.
Publicado: (2010)

Skin and fat necrosis of the breast following methylene blue dye injection for sentinel node biopsy in a patient with breast cancer
por: Salhab, M, et al.
Publicado: (2005)

The role of subareolar methylene blue in identifying the sentinel node in patients with invasive breast cancer
por: Mostafa, A, et al.
Publicado: (2001)

Assessment of sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer in two subgroups: Initially node negative and node positive converted to node negative – A systemic review and meta-analysis
por: Shirzadi, Alireza, et al.
Publicado: (2019)

Skin-sparing mastectomy and radiotherapy: an update
por: Mokbel, Ramia, et al.
Publicado: (2006)

A Nomogram for Identifying HR+/Her2− Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib Therapy
por: Yang, Hanzhao, et al.
Publicado: (2023)

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy
por: van Roozendaal, L. M., et al.
Publicado: (2016)

Can Axillary Lymph Node Dissection Be Safely Omitted for Early-Stage Breast Cancer Patients with Sentinel Lymph Node Micrometastasis?
por: Damle, Sameer, et al.
Publicado: (2009)

The Oncological Safety of Nipple-Sparing Mastectomy: A Systematic Review of the Literature with a Pooled Analysis of 12,358 Procedures
por: Headon, Hannah Louise, et al.
Publicado: (2016)

Intraoperative molecular analysis of sentinel lymph nodes following neoadjuvant chemotherapy in patients with clinical node negative breast cancer: An institutional study
por: Parada, David, et al.
Publicado: (2016)

Sentinel Node Biopsy after Neoadjuvant Chemotherapy for Breast Cancer: Preliminary Experience with Clinically Node Negative Patients after Systemic Treatment
por: Sanchez, Alejandro Martin, et al.
Publicado: (2021)

Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update
por: Mokbel, Ramia, et al.
Publicado: (2006)

Risk Factors for a False-Negative Result of Sentinel Node Biopsy in Patients with Clinically Node-Negative Breast Cancer
por: Lee, Seung Ah, et al.
Publicado: (2018)

Locoregional therapy of the primary tumour in de novo stage IV breast cancer in 216 066 patients: A meta-analysis
por: Gera, Ritika, et al.
Publicado: (2020)

Reflector-Guided Localisation of Non-Palpable Breast Lesions: A Prospective Evaluation of the SAVI SCOUT(®) System
por: Wazir, Umar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cgpdjq0k5d4hi3mm7kvmh516ul